Ani Pharmaceuticals (ANIP) Current Deferred Tax Assets (2014 - 2015)

Ani Pharmaceuticals has disclosed Current Deferred Tax Assets across 2 years of filings, most recently posting $8.3 million for Q3 2015.

• Current Deferred Tax Assets for Q3 2015 came in at $8.3 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2015 was $8.3 million (changed N/A YoY), and the FY2014 annual result was $7.6 million, changed N/A from the prior year.
• Current Deferred Tax Assets came in at $8.3 million for Q3 2015 at Ani Pharmaceuticals, up from $8.0 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $8.3 million in Q3 2015 to a low of $7.6 million in Q4 2014.